Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 20 Results

Title
Intervention Indication Therapeutic Area Year Actions
Netarsudil plus latanoprost (Roclatan) for glaucoma or ocular hypertension Roclatan (Roclanda; PG324) (fixed dose combination: Netarsudil mesylate; Latanoprost) Glaucoma , Ocular hypertension Ophthalmology 2017 View  |  Download
Pegcetacoplan for treating geographic atrophy Pegcetacoplan (APL-2) Geographic atrophy Ophthalmology 2021 View  |  Download
Ranibizumab Biosimilar for Age-related Macular Degeneration Ranibizumab biosimilar (FYB201; BI695511; PF582; QL1205; Xlucane; SB11) Age-related macular degeneration (AMD) Ophthalmology 2021 View  |  Download
Ranibizumab for proliferative and non-proliferative diabetic retinopathy Ranibizumab (Lucentis Port Delivery System; Lucentis) Diabetic retinopathy Endocrine Nutritional and Metabolic Disorders , Ophthalmology 2018 View  |  Download
Ranibizumab for Retinopathy of Prematurity – first line Ranibizumab (Lucentis Port Delivery System; Lucentis) Retinopathy of prematurity Gynaecology and Obstetrics , Ophthalmology 2018 View  |  Download
Ranibizumab port delivery system for the treatment of age-related macular degeneration Ranibizumab (Lucentis Port Delivery System; Lucentis) Age-related macular degeneration (AMD) Ophthalmology 2020 View  |  Download
Ranibizumab port delivery system for treating
diabetic macular oedema
Ranibizumab (Lucentis Port Delivery System; Lucentis) Diabetic macular oedema Endocrine, nutritional and metabolic disorders , Ophthalmology 2022 View  |  Download
Ravulizumab for treatment of neuromyelitis optica spectrum disorder Ravulizumab (ALXN1210; Ultomiris) Neuromyelitis optica spectrum disorders Nephrology , Ophthalmology 2022 View  |  Download
SA-237 for neuromyelitis optica and neuromyelitis optica spectrum disorders Satralizumab (SA237; RG6168) Neuromyelitis optica , Neuromyelitis optica spectrum disorders Neurology , Ophthalmology 2017 View  |  Download
Timrepigene emparvovec for choroideremia Timrepigene emparvovec (BIIB111; AAV2-REP1; NSR-REP1) Choroideremia Ophthalmology 2020 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications